Literature DB >> 10490001

Comparison of self-reported fecal occult blood testing with automated laboratory records among older women in a health maintenance organization.

M T Mandelson1, A Z LaCroix, L A Anderson, M R Nadel, N C Lee.   

Abstract

Screening guidelines for colorectal cancer recommend annual fecal occult blood (FOB) testing for adults aged 50 years and older. Self-reported history of screening is frequently the sole source of data available to researchers and clinicians. This study validated FOB testing in a sample of 1,021 older women. Testing rates based on self-reported data exceeded rates based on computerized laboratory records by 13.9%. Agreement was moderate (kappa = 0.52; 95% confidence interval 0.47, 0.58). Sensitivity was 0.92 and specificity 0.58. Logistic regression analysis showed that older age and physician encouragement for FOB testing were associated with accurate recall (p<0.05). Self-report is the most commonly available information about the occurrence and timing of cancer detection procedures. These data suggest cautious use of self-reported screening by FOB for clinical decision making and for research and surveillance.

Entities:  

Mesh:

Year:  1999        PMID: 10490001     DOI: 10.1093/oxfordjournals.aje.a010060

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  21 in total

1.  Barriers to colorectal cancer screening with fecal occult blood testing in a predominantly minority urban population: a qualitative study.

Authors:  Corey H Brouse; Charles E Basch; Randi L Wolf; Celia Shmukler; Alfred I Neugut; Steven Shea
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

2.  Factors associated with participation in colorectal cancer screening in Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV).

Authors:  Jun-Pyo Myong; Jin-Yong Shin; Su-Jin Kim
Journal:  Int J Colorectal Dis       Date:  2012-02-22       Impact factor: 2.571

3.  Correlates of self-reported colorectal cancer screening accuracy in a multi-specialty medical group practice.

Authors:  Arica White; Sally W Vernon; Jan M Eberth; Jasmin A Tiro; Sharon P Coan; Peter N Abotchie; Anthony Greisinger
Journal:  Open J Epidemiol       Date:  2013-02

4.  Effectiveness of a theory-based intervention to increase colorectal cancer screening among Iranian health club members: a randomized trial.

Authors:  Hamideh Salimzadeh; Hassan Eftekhar; Reza Majdzadeh; Ali Montazeri; Alireza Delavari
Journal:  J Behav Med       Date:  2013-09-13

5.  Testing a culturally appropriate, theory-based intervention to improve colorectal cancer screening among Native Hawaiians.

Authors:  Kathryn L Braun; Megan Fong; Momi E Kaanoi; Martina L Kamaka; Carolyn C Gotay
Journal:  Prev Med       Date:  2005-06       Impact factor: 4.018

6.  Comparing colorectal cancer screening and immunization status in older americans.

Authors:  Carrie N Klabunde; Helen I Meissner; Karen G Wooten; Nancy Breen; James A Singleton
Journal:  Am J Prev Med       Date:  2007-07       Impact factor: 5.043

7.  Validation of self-reported history of colorectal cancer screening.

Authors:  Shariq Khoja; S Elizabeth McGregor; Robert J Hilsden
Journal:  Can Fam Physician       Date:  2007-07       Impact factor: 3.275

8.  Self-report versus medical records for assessing cancer-preventive services delivery.

Authors:  Jeanne M Ferrante; Pamela Ohman-Strickland; Karissa A Hahn; Shawna V Hudson; Eric K Shaw; Jesse C Crosson; Benjamin F Crabtree
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

Review 9.  Does colorectal cancer risk perception predict screening behavior? A systematic review and meta-analysis.

Authors:  Thomas M Atkinson; Talya Salz; Kaitlin K Touza; Yuelin Li; Jennifer L Hay
Journal:  J Behav Med       Date:  2015-08-18

10.  Increasing uptake of colorectal cancer screening in Korea: a population-based study.

Authors:  Kui Son Choi; Jae Kwan Jun; Hoo-Yeon Lee; Myung-Il Hahm; Jae Hwan Oh; Eun-Cheol Park
Journal:  BMC Public Health       Date:  2010-05-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.